The largest database of trusted experimental protocols

Amicon ultra 30k centrifugal filters

Manufactured by Merck Group
Sourced in Germany, United States, Ireland

Amicon Ultra 30K centrifugal filters are a type of laboratory equipment used for sample preparation and purification. The filters feature a 30,000 Dalton molecular weight cutoff membrane that can be used to concentrate and purify macromolecules such as proteins, enzymes, and antibodies from complex mixtures.

Automatically generated - may contain errors

5 protocols using amicon ultra 30k centrifugal filters

1

Purification of Histidine-Tagged Pl-LAAO Protein from E. coli

Check if the same lab product or an alternative is used in the 5 most similar protocols
One colony of Escherichia coli strain CD03 containing pET15b with Pl-laao gene fused to a N-terminal hexahistidine tag was incubated until it reached an OD600~0.6 in an LB medium, with the addition of 50 μg/mL ampicillin at 37 °C and 250 rpm. Next, the protein expression was induced with isopropyl-β-d-thiogalactopyranoside (IPTG) 1 mM. Then, the cultures were incubated overnight at 25 °C, before they were harvested by centrifugation at 5000× g for 10 min. The cell pellet was resuspended in a binding buffer (50 mM sodium phosphate, 500 mM NaCl, 20 mM imidazole, pH 7.4) and was disrupted by sonication using a Braun Labsonic M sonicator. The homogenate was centrifuged at 13,000× g for 2 min, and the pellet was discarded. A cell lysate containing the soluble proteins was applied to columns with 1.5 mL of Qiagen Ni-NTA resin. The proteins attached to the column were eluted with an elution buffer (50 mM sodium phosphate, 500 mM NaCl and 500 mM imidazole, pH 7.4). Amicon® Ultra centrifugal filters 30K (Merck, Darmstadt, Germany) were applied to remove the imidazole.
+ Open protocol
+ Expand
2

Determination of Digoxin Encapsulation Efficiency

Check if the same lab product or an alternative is used in the 5 most similar protocols
Encapsulation efficiency (EE) of digoxin was determined by HPLC. A standard calibration curve was previously obtained (y = 292.67 x + 17.595, R2 = 0.999). HPLC chromatography was performed according to the conditions described previously [55 (link)], with a column C18 (Acclaim™ 120 Reversed-Phase Columns C18, 5 μm, 4.6 × 150 mm, Thermo Scientific) at a temperature of 35 °C and the mobile phase (mixture of water and acetonitrile, 72:28% (v/v)) was pumped at a flow rate of 0.8 mL/min. The run time cycle was completed in 20 min. Peak areas registered at 218 nm were used for digoxin quantification. All experiments were carried out in triplicate.
The EE indicates the drug amount into nanoparticles and was determined after ultrafiltration-centrifugation (Amicon® Ultra Centrifugal Filters, 30k; Merck Millipore, Billerica, MA, USA). The filtrate, containing the unencapsulated drug, which can pass through the filter membrane during centrifugation (4000× g; 10 min), was analyzed by HPLC. Encapsulation efficiency was calculated using the following Equation (4):  EE (%)=Actual amount of drugloaded in nanoparticlesTheory amount of drugloaded in nanoparticles×100
+ Open protocol
+ Expand
3

SARS-CoV-2 Spike Protein TLR4 Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Medium from Vero/dKI-low cells infected by SARS/D614G was collected at 20 hours p.i. and UV-inactivated as described above. The medium was then passed through a 0.22-μm filter, and virion-free samples were generated by ultracentrifugation. Media from cells infected with VEE replicons expressing different S protein variants were passed through a 0.22-μm filter. Supernatants and media were concentrated 20- to 30-fold using Amicon Ultra 30K centrifugal filters (Millipore). The concentrations of S1 subunit were determined indirectly by WB using commercial recombinant S1 with known concentration (no. S1N-C52H3, Acro Biosystems) as a reference. Analysis of TLR4 activation was performed on HEK-Blue hTLR4 cells (no. hkb-htlr4, InvivoGen) according to the manufacturer’s instructions (InvivoGen). S1 subunit was added to cells to a final concentration of 1 μg/mL. Lipopolysaccharide from E. coli K12 (LPS-EK; no. tlrl-peklps, InvivoGen) was used as a positive control at a concentration of 20 ng/mL. The concentrated samples of VP-SF medium harvested from the cells infected with VEErep/GFP were applied as a negative control.
+ Open protocol
+ Expand
4

Cisplatin-Induced DNA Damage Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genomic DNA was isolated from blood with Gentra Puregene Blood kit (Qiagen, cat no. 158389) according to the manufacturer’s instructions. DNA (7.5 μg) was digested with 3 U/μg DNA Mbo I (10 U/μl, Thermo Scientific, cat no. ER0812) at 37°C for 1 h. The DNA was purified with Amicon Ultra 30K centrifugal filters (Millipore, cat no. UFC503024) and divided into 1 μg aliquots. Treatment of DNA with cisplatin (cis-Diamminedichloroplatinum(II)) was done according to Murray et al. (24 (link)). In a total volume of 100 μl, 1 μg DNA was incubated in 25 mM Tris–HCl, pH 7.8 with 1–15 μM of cisplatin (Sigma-Aldrich, cat no. 479306), at 37°C for 18 h in the dark. The DNA was ethanol precipitated with sodium acetate and resuspended in 3 μl TE buffer (10 mM Tris–HCl, 1 mM ethylenediaminetetraacetic acid (EDTA), pH 8.0). For denaturation experiments, 1 μg human genomic DNA, in 3 μl TE, was heated up at 94°C for 4 min. Plasmid pUC 18 was digested with Hinf I (Thermo Scientific, cat no. ER0801) and Ssp I (Thermo Scientific, cat no. ER0771) 1.5 U enzyme per microgram DNA, prior to cisplatin treatment.
+ Open protocol
+ Expand
5

Purification of Recombinant Enzymes from E. coli

Check if the same lab product or an alternative is used in the 5 most similar protocols
E. coli C41(DE3) with plasmid constructions pET29c::Ma1, pET29c::Ma2, pET29c::Ab and pET29c::tDGAT were grown in 2 l flasks containing 1 l LB supplemented with 50 ug/ml kanamycin sulfate and induced with 1 mM IPTG when the OD600nm was approximately 0.6. Cell cultures were collected 3 hours later by centrifuging in a JA10 rotor (Beckman Coulter, Brea, CA) at 4,400 g for 15 minutes a 4°C and stored frozen at -20°C until analyzed. The supernatants were discarded and the pellets were resuspended in buffer A (NaCl 1 M, TrisHCl 50 mM pH 7.5 and PMSF 100 μl), sonicated and clarified by ultracentrifugation at 100,000 g for 15 minutes at 4°C. Supernatants were loaded onto a Níckel HisTrap HP column (GE Healthcare, 5 ml) previously equilibrated with buffer A. The His-tagged bound proteins were eluted by a gradient of concentration of imidazole (0-300mM; Sigma, St. Louis, MO). In order to improve the purification, the eluted protein was concentrated using Amicon Ultra 30k Centrifugal filters (Millipore, Ireland) and loaded into a size-exclusion chromatography Superdex 75 GL10_30 column (Amersham Pharmacia Biotech, UK) previously equilibrated with buffer B (NaCl 150 mM TrisHCl 50 mM pH 7.5 1 mM EDTA). Purified proteins were stored at -80°C in glycerol 20% for further experiments.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!